2
3

To amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes.

2/11/2026, 9:06 AM

Summary of Bill HR 7352

H.R. 7352, introduced in the 119th Congress on February 4, 2026, aims to amend the Public Health Service Act by creating a program focused on developing innovative antimicrobial drugs targeting difficult pathogens and severe infections.

Current Status of Bill HR 7352

Bill HR 7352 is currently in the status of Bill Introduced since February 4, 2026. Bill HR 7352 was introduced during Congress 119 and was introduced to the House on February 4, 2026.  Bill HR 7352's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of February 4, 2026

Bipartisan Support of Bill HR 7352

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
18
Democrat Cosponsors
9
Republican Cosponsors
9
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 7352

Primary Policy Focus

Comments